The current state of knowledge about the possible aetiology of tumours of the urinary bladder is summarised. An epidemiological enquiry at a tyre factory is described, where a hazard from antioxidants containing the carcinogenic compound beta-naphthylamine existed prior to 1949. An account was taken of the interrelationship between time and place of work, when outlining the dynamics of 33 tumours of the bladder occurring in the current or ex-factory population between 1948 and 1967. The majority (2/3) of the neoplasms were carcinoma (22); the remainder (11) were papilloma. In 15 out of 30 individuals there was conclusive evidence of exposure to the carcinogen as fume or powder. Handling the powder carried the greatest risk of developing a tumour, which was estimated to be between 7–10% of those involved. Among a population of 1,400 men at risk before 1949, when the hazard theoretically ceased, 10 cases of carcinoma of the urinary bladder were found (3.5 expected), in addition to 6 cases of papilloma (1.4 expected). Further analysis suggested that the position with regard to rubber workers only engaged after 1950 requires to be kept under continuing review.

This content is only available via PDF.
© 1969 S. Karger AG, Basel
1969
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.